Your browser doesn't support javascript.
loading
Early Stage Professionals Committee proceedings from the International Society for Cell & Gene Therapy 2022 Annual Meeting.
Lamb, Margaret; Wiest, Elani; Filiano, Anthony; Russell, Athena; Yarani, Reza; Sutrave, Gaurav; Durand, Nisha; Burga, Rachel A.
Afiliación
  • Lamb M; Pediatrics, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Wiest E; Center for Regenerative Medicine, Mayo Clinic Florida, Jacksonville, Florida, USA.
  • Filiano A; Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina, USA.
  • Russell A; Center for Cellular Immunotherapies, Philadelphia, Pennsylvania, USA.
  • Yarani R; Steno Diabetes Center Copenhagen, Copenhagen, Denmark.
  • Sutrave G; Faculty of Medicine and Health (FML), FML Medical Research Institutes, University of Sydney, Sydney Australia.
  • Durand N; Center for Regenerative Medicine, Mayo Clinic Florida, Jacksonville, Florida, USA.
  • Burga RA; Obsidian Therapeutics, Cambridge, Massachusetts, USA. Electronic address: rachel.burga@gmail.com.
Cytotherapy ; 25(6): 590-597, 2023 06.
Article en En | MEDLINE | ID: mdl-36906481
ABSTRACT
In this Committee Proceedings, representatives from the Early Stage Professional (ESP) committee highlight the innovative discoveries and key take-aways from oral presentations at the 2022 International Society for Cell and Gene Therapy (ISCT) Annual Meeting that cover the following subject categories Immunotherapy, Exosomes and Extracellular Vesicles, HSC/Progenitor Cells and Engineering, Mesenchymal Stromal Cells, and ISCT Late-Breaking Abstracts.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Madre Mesenquimatosas / Tratamiento Basado en Trasplante de Células y Tejidos Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Madre Mesenquimatosas / Tratamiento Basado en Trasplante de Células y Tejidos Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos